HOME > Investors > Press Releases
2017-09-22
VM202-ALS update release on ALS News Today
2017-09-12
DPhil. Sunyoung Kim, CSO of ViroMed, "Our gene therapy research is sailing through, and we are preparing for commercial production."
2017-08-25
Strides Toward New Approaches: Dawn of a New Era in DFU Treatment
2017-08-07
ViroMed Gene Therapy for Non-Healing Diabetic Foot Ulcers Starts Phase III Trial
2017-08-04
VM BioPharma began dosing of VM202 in Phase 3 for Non-Healing Diabetic Foot Ulcers
1 2 3 4 5 6 7 8 9 10